1-17 of 17
Felix Carbonell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective, Observational Study to Assess the Safety of Rituximab(R) in Combination with Chemotherapy in Patients with Previously-Untreated or Relapsed or Refractory B Cell-Lineage Chronic Lymphocytic Leukaemia (B-CLL): Final Results

Free
Pilar Giraldo, MD PhD, Andres Lopez, MD PhD, Eduardo Rios, MD, Felix Carbonell, MD PhD, Javier Lopez, Angel Ramírez, MD, Alicia Rodriguez, MD, Marta Gomez, MD, Ricardo Garcia, MD, Patricia Baltasar, MD, Maria Duran, MD, Raul Perez, MD, Maria Garcia, MD, José Antonio Márquez, Javier De la Serna, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5666.
https://doi.org/10.1182/blood.V124.21.5666.5666
Published: 2014
Journal Articles

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

Free
Pau Abrisqueta, Neus Villamor, María José Terol, Eva González-Barca, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A. García-Marco, Yolanda González, Felix Carbonell, Secundino Ferrer, Encarna Monzó, Isidro Jarque, Ana Muntañola, Mireia Constants, Lourdes Escoda, Xavier Calvo, Sabela Bobillo, José Bruno Montoro, Emili Montserrat, Francesc Bosch
Journal: Blood
Blood (2013) 122 (24): 3951–3959.
https://doi.org/10.1182/blood-2013-05-502773
Published: 2013
Includes: Supplemental data
Journal Articles

Assessment of Minimal Residual Disease Levels in B-CLL After Front-Line Treatment with FC-R and Rituximab Maintenance

Free
Jose A. Garcia-Vela, MD, Javier Lopez, Secundino Ferrer, Pilar Giraldo, Eva González-Barca, Eulogio Conde, Marcos González, Jose-Luis Guzman, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel De Paz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Rafael Martinez, MD, Carmen Burgaleta, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Felix Carbonell, MD, Jose A Garcia-Marco
Journal: Blood
Blood (2012) 120 (21): 4599.
https://doi.org/10.1182/blood.V120.21.4599.4599
Published: 2012
Journal Articles

Clinical and Biological Characterization of Patients with Low/Intermediate-1 Risk Myelodysplastic Syndrome and Iron Overload

Free
David Ivars, PhD, Rosa Collado, PhD, Carmen Alguero, M Carmen Tormos, Laura Diaz, Jose Luis Garcia-Gimenez, PhD, Beatriz Arrizabalaga, MD, Mayte Orero, MD, PhD, Pedro Perez, MD, Magdalena Sanchez, MD, PhD, M Angeles Ruiz, MD, PhD, Nuria Yagüe, MD, Reyes Sancho-Tello, MD, Ana Regadera, MD, Mar Tormo, Mercedes Egea, Elena Vidal, J Enrique O'Connor, PhD, Guillermo T Saez, MD, PhD, Felix Carbonell, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4956.
https://doi.org/10.1182/blood.V120.21.4956.4956
Published: 2012
Journal Articles

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Free
Pau Abrisqueta, MD, Neus Villamor, MD, PhD, María José Terol, MD, PhD, Eva González-Barca, MD, PhD, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose Antonio García-Marco, MD, PhD, Yolanda González, MD, Felix Carbonell, MD, PhD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, MD, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD, Francesc Bosch, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3930.
https://doi.org/10.1182/blood.V120.21.3930.3930
Published: 2012
Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Free
Francesc Bosch, MD, PhD, Pau Abrisqueta, Neus Villamor, MD. PhD, María José Terol, MD, PhD, Eva González-Barca, MD, Marcos González, MD, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A. Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD
Journal: Blood
Blood (2011) 118 (21): 293.
https://doi.org/10.1182/blood.V118.21.293.293
Published: 2011
Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) Sustains the Response Obtained After First-Line Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM).

Free
Francesc Bosch, MD, PhD, Neus Villamor, Pau Abrisqueta, MD, María José Terol, Eva González-Barca, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD
Journal: Blood
Blood (2010) 116 (21): 1382.
https://doi.org/10.1182/blood.V116.21.1382.1382
Published: 2010
Journal Articles

A Retrospective Population-Based Study of a Series of 307 Treatment-naïve Patients with Chronic Lymphocytic Leukemia (CLL): Study of the Clinical Features and Efficacy of First-Line Therapy

Free
Eva Ma Donato, MB, Rafa Andreu, MB, Aurelio Lopez, MB, Ana Vicente, MB, Ana Carral, MD, Isidro Jarque, MD, M. Angeles Ruiz, MD, Felix Carbonell, MD, Mar Osma, MD, Margarita Blanes, MB, Rosa Ferrer, MD, Alfonso Garcia, MD, Francisca Marin, MB, Pablo Lorente, MB, Ma Dolores Garcia, MB, Ma Fernanda Palmero, MB, Jose Antonio Fernandez, MD, Mario Montagud, MD, Miguel Blanquer, MB, Ma Jose Lis, MB, Paula Irene Petruskevicius, Mar Tormo, MD, PhD, María José Terol, MD
Journal: Blood
Blood (2010) 116 (21): 2452.
https://doi.org/10.1182/blood.V116.21.2452.2452
Published: 2010
Journal Articles

Rituximab Maintenance Treatment After Combined Fludarabine, Cyclophosphamide and Rituximab In Previously Untreated Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CLL): Interim Analysis of An Ongoing Phase II Multicenter Trial On Behalf of the Spanish CLL Study Group (GELLC)

Free
Jose A Garcia-Marco, MD, PhD, Javier Lopez-Jimenez, MD, Secundino Ferrer, MD, Pilar Giraldo, MD, PhD, Eva González-Barca, MD, Belen Navarro, MD, Eulogio Conde, MD, PhD, Marcos González, Jose L. Guzman, MD, Ernesto Perez, MD, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel de Paz, MD, M. Angeles Ruiz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Helena Bañas, MD, M. Carmen Fernandez, MD, Rafael Martinez, MD, Carmen Burgaleta, MD, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Ana Carral, MD, Inmaculada Fuentes, MD, Eva Donato, MD, Paola Leon, MD, Felix Carbonell, MD, Jose A. Garcia-Vela, MD
Journal: Blood
Blood (2010) 116 (21): 2448.
https://doi.org/10.1182/blood.V116.21.2448.2448
Published: 2010
Journal Articles

A New Prognostic Scoring System Including Transfusion Dependency and Cytogenetic Abnormalities for Patients with Chronic Myelomonocytic Leukemia.

Free
Esperanza Such, Jose Cervera, Benet Nomdedeu, Carmen Pedro, Javier Bueno, Teresa Bernal, Felix Carbonell, Mohamed Belkaid, Leonor Senent, Francesc Sole, Elisa Luño, Teresa Vallespi, Rosa Collado, Teresa Ardanaz, Ma, Fernando Ramos, Mar Tormo, Reyes Sancho-Tello, Maria Consuelo del Cañizo, Blanca Xicoy, Victor Marco, Valle Gomez, Santiago Bonanad, Ana Valencia, Mar Mallo, Luis Benlloch, Guillermo Sanz
Journal: Blood
Blood (2009) 114 (22): 1750.
https://doi.org/10.1182/blood.V114.22.1750.1750
Published: 2009
Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with More Than 15% of Ring Sideroblasts in Bone Marrow: An Overlapping Disorder Between CMML and Refractory Anemia with Ring Sideroblasts.

Free
Esperanza Such, Leonor Senent, Benet Nomdedeu, Javier Bueno, Teresa Bernal, Felix Carbonell, Jose Cervera, Lourdes Florensa, Maria Consuelo del Cañizo, Mohamed Belkaid, Teresa Vallespi, Elisa Luño, Marisa Orero, Carmen Pedro, Mar Tormo, Ma Teresa Ardanaz, Fernando Ramos, Raquel de Paz, Victor Marco, Valle Gomez, Leonor Arenillas, Santiago Bonanad, Blanca Xicoy, Reyes Sancho-Tello, Rafael Andreu, Beatriz Arrizabagala, Ana Villegas, Federico Moscardo, Luis Benlloch, Guillermo Sanz
Journal: Blood
Blood (2009) 114 (22): 290.
https://doi.org/10.1182/blood.V114.22.290.290
Published: 2009
Journal Articles

Chronic Lymphocytic Leukemia: Correlations Between Oxidative Stress Metabolism and Cytogenetic Subgroups

Free
Felix Carbonell, Isabel Oliver, Rosa Collado, Carmen Tormos, Antonio Iradi, Maite Orero, Concepción Cerda, Susana Beltran, Ana Del Rey, Amparo Miguel, Guillermo Sáez
Journal: Blood
Blood (2008) 112 (11): 4157.
https://doi.org/10.1182/blood.V112.11.4157.4157
Published: 2008
Journal Articles

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

Free
Guillermo Sanz, MD, PhD, Benet Nomdedeu, MD, Esperanza Such, Teresa Bernal, MD, Mohamed Belkaid, Ma Teresa Ardanaz, MD, Victor Marco, MD, Carme Pedro, MD, Fernando Ramos, MD, PhD, MPH, Maria Consuelo del Cañizo, MD, PhD, Elisa Luño, MD, Francesc Cobo, MD, Felix Carbonell, MD, Valle Gomez, MD, Juan A Muñoz, MD, Mari Luz Amigo, MD, Alicia Bailen, MD, Santiago Bonanad, MD, Mar Tormo, MD, Rafael Andreu, Beatriz Arrizabalaga, MD, Maria J. Arilla, MD, Javier Bueno, MD, Maria J. Requena, MD, Joan Bargay, MD, Joaquin Sanchez, MD, Leonor Senent, MD, Leonor Arenillas, MD, Raquel de Paz, MD, PhD, Blanca Xicoy, MD, Rafael Duarte, MD, PhD, Jose Cervera, MD
Journal: Blood
Blood (2008) 112 (11): 640.
https://doi.org/10.1182/blood.V112.11.640.640
Published: 2008
Journal Articles

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM) Is a Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia.

Free
Francesc Bosch, MD, PhD, Pau Abrisqueta, MD, Neus Villamor, MD, PhD, Maria Jose Terol, MD, Josep-Maria Ribera, MD, Eva Gonzalez-Barca, MD, Marcos Gonzalez, MD, Eugenia Abella, MD, Julio Delgado, MD, Yolanda Gonzalez, MD, Secundino Ferrer, MD, Felix Carbonell, MD, Lourdes Escoda, MD, Isidro Jarque, MD, Encarnacion Monzo, MD, Ana Muntañola, MD, Olga Salamero, MD, Emili Montserrat, MD
Journal: Blood
Blood (2008) 112 (11): 2097.
https://doi.org/10.1182/blood.V112.11.2097.2097
Published: 2008
Journal Articles

Response Predictive Factors to Anagrelide in Essential Thrombocythemia Diagnosed Patients.

Free
Carlos Besses, MD, PhD, Manuel Giralt, MD, PhD, Luis Hernandez-Nieto, MD, PhD, Carmen Burgaleta, MD, PhD, Victor Navas, MD, PhD, Gema Ramirez, MD, PhD, Vicente Vicente, MD, PhD, Felix Carbonell, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4649.
https://doi.org/10.1182/blood.V110.11.4649.4649
Published: 2007
Journal Articles

Preliminary Results of the Combination Rituximab, Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) Followed by Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukemia (CLL).

Free
Francesc Bosch, MD, PhD, Ana Muntañola, MD, Neus Villamor, MD, Maria Jose Terol, MD, Elena Gonzalez-Barca, MD, Josep Maria Ribera, MD, PhD, Marcos Gonzalez, MD, Eugenia Abella, MD, Julio Delgado, MD, Felix Carbonell, MD, PhD, Jose A. Garcia-Marco, MD, PhD, Lourdes Escoda, MD, Secundino Ferrer, MD, E. Monzo, MD, Yolanda Gonzalez, MD, Pau Abrisqueta, MD, Olga Salamero, MD, Eva Gine, MD, Emili Montserrat, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 626.
https://doi.org/10.1182/blood.V110.11.626.626
Published: 2007
Journal Articles

Automated Neutrophil Morphology and Its Utility in the Assessment of Neutrophil Dysplasia and in the Diagnosis of Myelodysplastic Syndromes.

Free
Amparo Miguel, PhD, Maite Orero, Ph.D., Rosa Collado, Pedro L. Perez, MD, Alejandro Pacios, MD, Felix Carbonell, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 4870.
https://doi.org/10.1182/blood.V108.11.4870.4870
Published: 2006